Abstract
Thromboembolism prophylaxis is both an important and vexing consideration for the arthroplasty surgeon. The American College of Chest Physicians (ACCP) guidelines led many surgeons to alter their previous strategy. Recently, the American Academy of Orthopaedic Surgeons (AAOS) work group published an alternate set of guidelines that incorporates assessment of risk. The AAHKS 2007 Rand Award Paper documented the efficacy of aspirin in the Medicare population (Bozic et al., AAHKS 2007). This is an observational cohort study examining the efficacy of thromboembolism prophylaxis in a dedicated arthroplasty practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
